Campbell NR - Search Results

1

Refining hypertension surveillance to account for potentially misclassified cases.

Peng M, Chen G, Lix LM, McAlister FA, Tu K, Campbell NR, Hemmelgarn BR, Svenson LW, Quan H; Hypertension Outcomes Surveillance Team. Peng M, et al. Among authors: campbell nr. PLoS One. 2015 Mar 24;10(3):e0119186. doi: 10.1371/journal.pone.0119186. eCollection 2015. PLoS One. 2015. PMID: 25803682 Free PMC article.

2

A novel process for updating recommendations for managing hypertension: rationale and methods.

Zarnke KB, Campbell NR, McAlister FA, Levine M; Canadian Hypertension Recommendations Working Group. Zarnke KB, et al. Among authors: campbell nr. Can J Cardiol. 2000 Sep;16(9):1094-102. Can J Cardiol. 2000. PMID: 11021953 Review. English, French.

3

The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future.

McAlister FA, Campbell NR, Zarnke K, Levine M, Graham ID. McAlister FA, et al. Among authors: campbell nr. CMAJ. 2001 Feb 20;164(4):517-22. CMAJ. 2001. PMID: 11233874 Free PMC article. Review.

4

Not all guidelines are created equal.

Campbell N, McAlister FA. Campbell N, et al. CMAJ. 2006 Mar 14;174(6):814-5; discussion 815. doi: 10.1503/cmaj.1060008. CMAJ. 2006. PMID: 16534092 Free PMC article. No abstract available.

5

Use of beta-blockers for uncomplicated hypertension in the elderly: a cause for concern.

Tu K, Campbell NR, Chen Z, McAlister FA. Tu K, et al. Among authors: campbell nr. J Hum Hypertens. 2007 Apr;21(4):271-5. doi: 10.1038/sj.jhh.1002128. Epub 2007 Feb 8. J Hum Hypertens. 2007. PMID: 17287848

6

Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada.

Joffres MR, Campbell NR, Manns B, Tu K. Joffres MR, et al. Among authors: campbell nr. Can J Cardiol. 2007 May 1;23(6):437-43. doi: 10.1016/s0828-282x(07)70780-8. Can J Cardiol. 2007. PMID: 17487286 Free PMC article.

7

Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006.

Hemmelgarn BR, Chen G, Walker R, McAlister FA, Quan H, Tu K, Khan N, Campbell N. Hemmelgarn BR, et al. Can J Cardiol. 2008 Jun;24(6):507-12. doi: 10.1016/s0828-282x(08)70627-5. Can J Cardiol. 2008. PMID: 18548150 Free PMC article.

8

Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada.

Campbell NR, Brant R, Johansen H, Walker RL, Wielgosz A, Onysko J, Gao RN, Sambell C, Phillips S, McAlister FA; Canadian Hypertension Education Program Outcomes Research Task Force. Campbell NR, et al. Hypertension. 2009 Feb;53(2):128-34. doi: 10.1161/HYPERTENSIONAHA.108.119784. Epub 2008 Dec 29. Hypertension. 2009. PMID: 19114646

9

Reducing costs and improving hypertension management.

Stankus V, Hemmelgarn B, Campbell NR, Chen G, McAlister FA, Tsuyuki RT. Stankus V, et al. Among authors: campbell nr. Can J Clin Pharmacol. 2009 Winter;16(1):e151-5. Epub 2009 Feb 4. Can J Clin Pharmacol. 2009. PMID: 19193969

10

Meta-analysis of adverse cardiovascular outcomes associated with antecedent hypertension after myocardial infarction.

Chen G, Hemmelgarn B, Alhaider S, Quan H, Campbell N, Rabi D. Chen G, et al. Am J Cardiol. 2009 Jul 1;104(1):141-7. doi: 10.1016/j.amjcard.2009.02.048. Epub 2009 May 4. Am J Cardiol. 2009. PMID: 19576336 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

491 results

Search Page